These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 26114156)
1. Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer. Yang YA; Yu J Genes Dis; 2015 Jun; 2(2):144-151. PubMed ID: 26114156 [TBL] [Abstract][Full Text] [Related]
2. Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program. Jin HJ; Zhao JC; Wu L; Kim J; Yu J Nat Commun; 2014 May; 5():3972. PubMed ID: 24875621 [TBL] [Abstract][Full Text] [Related]
3. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. Sahu B; Laakso M; Ovaska K; Mirtti T; Lundin J; Rannikko A; Sankila A; Turunen JP; Lundin M; Konsti J; Vesterinen T; Nordling S; Kallioniemi O; Hautaniemi S; Jänne OA EMBO J; 2011 Sep; 30(19):3962-76. PubMed ID: 21915096 [TBL] [Abstract][Full Text] [Related]
4. FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression. Zhao JC; Fong KW; Jin HJ; Yang YA; Kim J; Yu J Oncogene; 2016 Aug; 35(33):4335-44. PubMed ID: 26751772 [TBL] [Abstract][Full Text] [Related]
5. Pioneer of prostate cancer: past, present and the future of FOXA1. Teng M; Zhou S; Cai C; Lupien M; He HH Protein Cell; 2021 Jan; 12(1):29-38. PubMed ID: 32946061 [TBL] [Abstract][Full Text] [Related]
6. FOXA1: a transcription factor with parallel functions in development and cancer. Bernardo GM; Keri RA Biosci Rep; 2012 Apr; 32(2):113-30. PubMed ID: 22115363 [TBL] [Abstract][Full Text] [Related]
8. Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function. Gui B; Gui F; Takai T; Feng C; Bai X; Fazli L; Dong X; Liu S; Zhang X; Zhang W; Kibel AS; Jia L Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14573-14582. PubMed ID: 31266892 [TBL] [Abstract][Full Text] [Related]
9. Hepatocyte nuclear factor-3 alpha (HNF-3alpha) negatively regulates androgen receptor transactivation in prostate cancer cells. Lee HJ; Hwang M; Chattopadhyay S; Choi HS; Lee K Biochem Biophys Res Commun; 2008 Mar; 367(2):481-6. PubMed ID: 18178153 [TBL] [Abstract][Full Text] [Related]
10. Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer. Gao S; Chen S; Han D; Wang Z; Li M; Han W; Besschetnova A; Liu M; Zhou F; Barrett D; Luong MP; Owiredu J; Liang Y; Ahmed M; Petricca J; Patalano S; Macoska JA; Corey E; Chen S; Balk SP; He HH; Cai C Nat Genet; 2020 Oct; 52(10):1011-1017. PubMed ID: 32868907 [TBL] [Abstract][Full Text] [Related]
12. Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially. Yu X; Gupta A; Wang Y; Suzuki K; Mirosevich J; Orgebin-Crist MC; Matusik RJ Ann N Y Acad Sci; 2005 Dec; 1061():77-93. PubMed ID: 16467259 [TBL] [Abstract][Full Text] [Related]
19. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells. Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853 [TBL] [Abstract][Full Text] [Related]
20. FoxA1 is a key mediator of hormonal response in breast and prostate cancer. Robinson JL; Carroll JS Front Endocrinol (Lausanne); 2012; 3():68. PubMed ID: 22649425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]